W
Weian Zeng
Researcher at Sun Yat-sen University
Publications - 40
Citations - 480
Weian Zeng is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 24 publications receiving 316 citations.
Papers
More filters
Journal ArticleDOI
The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma
TL;DR: Treatment of small HCC by RFA under general anesthesia is associated with reduced risk of cancer recurrence and no effect of anesthetic technique on overall survival is detected.
Journal ArticleDOI
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target
TL;DR: Clinical and biological evidence revealed that MOP-mediated epithelial-mesenchymal transition promotes HCC metastasis and poor prognosis and MOP inhibitors may be a promising strategy for HCC therapy.
Journal ArticleDOI
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
TL;DR: The results suggest that cGAS-STING pathway members may be used as prognostic biomarkers and immunotherapeutic targets HCC patients.
Journal ArticleDOI
Impact of preoperative anemia on relapse and survival in breast cancer patients
Ying Jun Zhang,Yu Yang Chen,Dong Tai Chen,Yu Jiang,Wan Huang,Han Dong Ouyang,Wei Xing,Mu Sheng Zeng,Xiaoming Xie,Weian Zeng +9 more
TL;DR: Preoperative anemia was independently associated with poor prognosis of patients with breast cancer, and Cox proportional hazards regression model indicated that preoperative anemic was an independent prognostic factor of LRFS, LNMFS, DMFS, RFS, and OS for patients with Breast cancer.
Journal ArticleDOI
The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
TL;DR: The Beta2-AR is a potential prognostic biomarker for survival and tumor recurrence in HCC patients after curative resection and was an excellent predictive factor for both recurrence-free survival and overall survival (OS).